Form D · Pharmaceuticals
Cullinan Mica Corp.
Cambridge, MA · CIK 0001814544
Offering snapshot reported Mar 21, 2022 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2022 | Initial | $10,000,000 | No comparison | 4 | SEC filing |
| Jun 10, 2020 | Initial | $16,588,638 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-438249
Source: Form D, filed Mar 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nadim Ahmed | Director, Executive |
| Neil W. Gibson, Ph.D. | Director |
| Owen Hughes | Director |
| Morana Jovan Embiricos | Director |
| Jay B. Lichter | Director |
| Asher Page | Executive |
| Anthony Rosenberg | Director |
| Leigh Zawel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Main Street Suite 520
Cambridge, MA, 02142
Cambridge, MA, 02142